All Updates

Washington, D.C. — La ley DIVERSE para ensayos clínicos (DIVERSE Trials Act), presentada tanto en la Cámara de Representantes como en el Senado, aumentaría la diversidad en los ensayos clínicos y facilitaría la participación de todos los pacientes con cáncer en ensayos clínicos. La legislación bipartidista y bicameral, respaldada por los Senadores Robert Menendez (D-N.J.) y Tim Scott (R-S.C.), y los Representantes Raul

RALEIGH, NC – Today, the North Carolina House of Representatives passed a state budget that included a proposal to establish a new revenue fund for the $40 million that North Carolina received as part of the settlement with e-cigarette company JUUL. The below statement can be attributed to Derwin

Today the president called on Congress to bring down patient prescription drug costs, an issue of critical importance to cancer patients. Among the provisions the president outlined was establishing an annual cap on Medicare enrollees’ out-of-pocket expenses.

Late last week the administration rescinded a proposed rule that would have tied the price of select Medicare Part B drugs to that of foreign countries. Of the 50 drugs selected for participation under the Most Favored Nation rule, 35 would have been cancer drugs.

More than two dozen patient groups and health care partners are joining forces to call for a comprehensive paid family and medical leave program, including caregiving leave.